The Citing articles tool gives a list of articles citing the current article. The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program . You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
Haleh Bagheri , Mireille Gony , Jean-Louis Montastruc
Thérapie, 60 3 (2005) 287-294
Published online: 2007-03-01
This article has been cited by the following article(s):
10 articles
Strategies implemented to address vaccine hesitancy in France: A review article
Cécile Fokoun Human Vaccines & Immunotherapeutics 14 (7) 1580 (2018) https://doi.org/10.1080/21645515.2018.1458807
Quelle PharmacoVigilance pour les vaccins ?
Jean-Louis Montastruc, Geneviève Durrieu, Isabelle Lacroix, Maryse Lapeyre-Mestre, Christine Damase-Michel, Haleh Bagheri and Agnès Sommet Bulletin de l'Académie Nationale de Médecine 200 (2) 241 (2016) https://doi.org/10.1016/S0001-4079(19)30755-1
First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines
Geneviève Durrieu, Aurore Palmaro, Laure Pourcel, et al. Drug Safety 35 (10) 845 (2012) https://doi.org/10.2165/11631800-000000000-00000
First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines
Geneviéve Durrieu, Aurore Palmaro, Laure Pourcel, Céline Caillet, Angeline Faucher, Alexis Jacquet, Shéhérazade Ouaret, Marie Christine Perault-Pochat, Carmen Kreft-Jais, Anne Castot, Maryse Lapeyre-Mestre and Jean-Louis Montastruc Drug Safety 35 (10) 845 (2012) https://doi.org/10.1007/BF03261980
Which Pharmacovigilance for Vaccines?
Hervé Le Louët, Elisabeth Loupi, Françoise Haramburu, et al. Therapies 62 (3) 245 (2007) https://doi.org/10.2515/therapie:2007039
Quelle pharmacovigilance pour les vaccins ?
Hervé Le Louët, Elisabeth Loupi, Françoise Haramburu, et al. Therapies 62 (3) 241 (2007) https://doi.org/10.2515/therapie:2007048
Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods
Jean-Louis Montastruc, Agnès Sommet, Isabelle Lacroix, et al. Joint Bone Spine 73 (6) 629 (2006) https://doi.org/10.1016/j.jbspin.2006.09.002
Surveillance post-AMM des vaccins
Odile Launay, Karine Petitprez and Mathie Lorrot Therapies 60 (3) 209 (2005) https://doi.org/10.2515/therapie:2005026
Surveillance of adverse effects during a vaccination campaign against meningitis C
Anne Laribière, Ghada Miremont-Salamé, Hadrien Reyre, et al. European Journal of Clinical Pharmacology 61 (12) 907 (2005) https://doi.org/10.1007/s00228-005-0053-3
Nouvelles méthodes d’étude du risque médicamenteux : l’expérience du Centre Midi-Pyrénées de Pharmacovigilance
Jean-Louis Montastruc, Haleh Bagheri, Isabelle Lacroix, et al. Bulletin de l'Académie Nationale de Médecine 189 (3) 493 (2005) https://doi.org/10.1016/S0001-4079(19)33561-7